Delivery Order SPE2DB24D8001-SPE2DB25FLAGY
Award Date 8/22/25
Potential Completion Date 8/25/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,425.36 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Jardiance 10 mg tablets (90-count packages). The contract, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed price pricing and carries no set-aside designation. This delivery order represents a continuation of Dakota Drug's role as a critical pharmaceutical supplier to the...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order valued at $1,895.71 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement. This award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.04 to Dakota Drug, Inc. for the supply of Jardiance 10 mg tablets (90-count) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a continuation of pharmaceutical supply services under the company's larger indefinite delivery contract with DLA Troop Support Medical's ECAT Generation V Program (SPE2DB24D8001), valued at $999,999,999.00 through December 31, 2025. The...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, received a delivery order award from the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count). This firm fixed-price delivery order, valued at $1,184.05, is expected to be completed by July 31, 2025, and represents performance at the vendor's Anoka, Minnesota location. The award carries no set-aside designation and operates under Dakota Drug's larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,766.92, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm-fixed-price delivery order, with an ultimate completion date of July 18, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Armed...
- This federal contract award, valued at $3,278.21, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Jardiance 10 mg tablets, a pharmaceutical product, to support medical operations for the U.S. Armed Forces. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide Jardiance 10 mg tablets. The contract, valued at $9,269.99, has an ultimate completion date of August 6, 2024. This award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which allows the company to supply a range of pharmaceutical products, medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,231,498 units of Jardiance 10 MG Tablet 90s medication. The contract has a ceiling value of $3,643.63 and a period of performance through July 24, 2024. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
- This award is a Delivery Order contract valued at $3,052.83, issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 25 MG TABLET 30S, a prescription medication. This order is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,703.89 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a period of performance through November 25, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC...